Navigation Links
Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Men's Health Watch
Date:9/5/2007

BOSTON, Sept. 5 /PRNewswire-USNewswire/ -- Men with slow urine flow from enlargement of the prostate gland (known as benign prostatic hyperplasia or BPH) should avoid anything that makes the situation worse--and that includes some medications. The most common offenders are over-the-counter cold and allergy remedies. Now, some research suggests that nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may also affect the prostate's function, reports the September 2007 issue of Harvard Men's Health Watch.

Researchers in the Netherlands found that the risk of acute urinary retention (severe difficulty urinating) was twice as high in men taking NSAIDs as in men who were not using them. By contrast, though, researchers in America evaluating the long-term effects of NSAIDs on the prostate found that daily NSAID use was linked to a reduced risk of developing BPH symptoms and slow urinary flow rates.

At first glance the studies seem contradictory, but a closer look suggests that NSAIDs may be both friend and foe, depending on the stage of BPH and the part of the urinary tract that's vulnerable.

The American study evaluated the onset of BPH symptoms. There is emerging evidence that inflammation may play a role in development of BPH. If that's the case, regular NSAID use might delay the onset of symptoms. The Dutch study, which evaluated established cases of acute urinary retention, found that men who had recently begun taking NSAIDs were at the highest risk. These men may already have been developing BPH for years before taking the NSAIDs. And the NSAIDs may have caused trouble by acting on the bladder, not the prostate.

Harvard Men's Health Watch suggests that if men notice an increase in BPH symptoms while taking an NSAID, they should inform their doctors and reduce or avoid NSAIDs.

Also in this issue:

-- How to increase "good" cholesterol

-- Help for restless legs syndrome

-- MRIs and stents: Incompatible?

Harvard Men's Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at http://www.health.harvard.edu/men or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Men's Health Watch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Syphilis uncovered
3. Mystery of nacrolepsy uncovered
4. Hospitals Health Insurance Scam Uncovered
5. Grapefruit juice could be taken along with medication: the nutrient-drug reaction uncovered!
6. New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders
7. Elusive Step In DNA Mutation Uncovered By Researchers
8. Brains Filing System Uncovered
9. The Anti-HIV Properties Of Green Tea Uncovered
10. CDC reveals relationship between prepregnant weight and heart defects in infants
11. Link between Constipation and Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... A stressful work environment can hurt the physical and emotional health of employees. ... workplace. The goal of Clearview Resolution Services has always been to help others, starting ... will be shutting down the office early on Fridays. The Clearview team will use ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: